What would happen in the show rings across the country if all the horses currently using Medroxy (MPA) were suddenly pulled off of it…?
This could cause many show ring nightmares for the horses pulled off of their MPA, but as well, miss-behaving horses can often upset the entire show.
Following the 2017 USEF Annual Meeting in January, USEF President Murray Kessler created a panel to investigate, analyze, and make recommendations to the Board of Directors concerning the use of MPA. The panel recommended that beginning September 1, 2017, the USEF would require medication report forms to be filed for horses treated with MPA if the horse had received treatment within three months of the competition start date.
This usage data along with additional proprietary research will be assessed once available and further recommendations, if indicated, will be made at that time.
In March 2017, the USEF conducted a public workshop to address concerns that have been voiced regarding the efficacy, safety, and use of MPA in competition horses. Then in June 2017, USEF hosted a joint Town Hall with the United States Hunter Jumper Association (USHJA) at the Upperville Colt and Horse Show.